메뉴 건너뛰기




Volumn 27, Issue 6, 2012, Pages 658-662

Different truncation methods of AUC between Japan and the EU for bioequivalence assessment: Influence on the regulatory judgment

Author keywords

AUC; Bioequivalence; Clinical pharmacokinetics; Drug development; Regulatory science; Sustained release formulation

Indexed keywords

GENERIC DRUG;

EID: 84871673850     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.DMPK-12-RG-033     Document Type: Article
Times cited : (2)

References (8)
  • 4
    • 85031145327 scopus 로고    scopus 로고
    • http://www.info.pmda.go.jp/psearch/html/menu_tenpu_base.html (2011).
    • (2011)
  • 5
    • 84871696452 scopus 로고    scopus 로고
    • (approval number: 22000AMX02222000)
    • Japanese package insert (approval number: 22000AMX02222000) (2009).
    • (2009) Japanese package insert
  • 6
    • 84871673882 scopus 로고    scopus 로고
    • (approval number: 21900AMX01126000)
    • Japanese package insert (approval number: 21900AMX01126000) (2010).
    • (2010) Japanese package insert
  • 7
    • 0025958371 scopus 로고
    • Sample size determination for bioequivalence assessment by means of confidence intervals
    • Diletti, E., Hauschke, D. and Steinijans, V. W.: Sample size determination for bioequivalence assessment by means of confidence intervals. Int. J. Clin. Pharmacol. Ther. Toxicol., 29: 1-8 (1991).
    • (1991) Int. J. Clin. Pharmacol. Ther. Toxicol. , vol.29 , pp. 1-8
    • Diletti, E.1    Hauschke, D.2    Steinijans, V.W.3
  • 8
    • 79961173953 scopus 로고    scopus 로고
    • Using partial area for evaluation of bioavailability and bioequivalence
    • Chen, M. L., Davit, B., Lionberger, R., Wahba, Z., Ahn, H. Y. and Yu, L. X.: Using partial area for evaluation of bioavailability and bioequivalence. Pharm. Res., 28: 1939-1947 (2011).
    • (2011) Pharm. Res. , vol.28 , pp. 1939-1947
    • Chen, M.L.1    Davit, B.2    Lionberger, R.3    Wahba, Z.4    Ahn, H.Y.5    Yu, L.X.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.